Atom Investors’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,510
Closed -$16.6K 464
2024
Q1
$16.6K Buy
+10,510
New +$16.6K ﹤0.01% 557